SEARCH

SEARCH BY CITATION

References

  • 1
    Parkin DM, Stjernswörd J, Muir CS. Estimates of the worldwide frequency of twelve major cancers. Bull WHO 1984; 62: 163182.
  • 2
    Parkin DM, Bray F, Devesa S. Cancer burden in the year 2000: the global picture. Eur J Cancer 2001; 37: S4S66.
  • 3
    Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5. Lyon, France: International Agency for Research on Cancer; 2001.
  • 4
    Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5 Version 2.0. Lyon, France: IARCPress; 2004.
  • 5
    Pisani P, Bray F, Parkin DM. Estimates of the worldwide prevalence of cancer for 25 cancers in the adult population. Int J Cancer 2002; 97: 7281.
  • 6
    Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int J Cancer 1999; 80: 827841.
  • 7
    Pisani P, Parkin DM, Bray Fl, Ferlay J. Estimates of the worldwide mortality from twenty-five major cancers in 1990. Implications for prevention, and projections of future burden. Int J Cancer 1999; 83: 1829.
  • 8
    Smith P. Comparison between Registries: Age Standardised Rates, in Cancer Incidence in Five Continents, Vol. V, IARC Scientific Publications No. 88. Lyon, France: International Agency for Research on Cancer; 1987.
  • 9
    Sant M, Aareleid T, Berrino F, et al. EUROCARE Working Group. EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary. Ann Oncol 2003; 14: v61v118.
  • 10
    RiesLAG, EisnerMP, KosaryCL, et al. (eds). SEER cancer statistics review, 1975–2001. Bethesda, MD: National Cancer Institute; 2004. Available at: http://seer.cancer.gov/csr/1975_2001/. Accessed December 22, 2004.
  • 11
    Gondos A, Chokunonga E, Brenner H, et al. Cancer survival in a Southern African urban population. Int J Cancer 2004; 112: 860864.
  • 12
    Gondos A, Brenner H, Wabinga H, et al. Cancer survival in Kampala, Uganda. Br J Cancer 2005 (in press).
  • 13
    SankaranarayananR, BlackRJ, ParkinDM (eds). Cancer Survival in Developing Countries, IARC Scientific Publications No. 15. Lyon, France: International Agency for Research on Cancer; 1988.
  • 14
    United Nations. World population prospects. The 2002 Revision. Population database. New York, NY: United Nations; 2003. Available at: Accessed December 22, 2004.
  • 15
    Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention, and projections of future burden. Int J Cancer 1993; 55: 891903.
  • 16
    Parkin DM, Hakulinen T. Analysis of survival In: JensenOM, ParkinDM, MaclennanR, et al. (eds). Cancer Registration, Principles and Methods, IARC Scientific Publications No. 95. Lyon, France: International Agency for Research on Cancer: 1991: 159176.
  • 17
    Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594606.
  • 18
    Doll R, Peto R. The Causes of Cancer. Oxford, UK; Oxford University Press; 1981.
  • 19
    Parkin DM, Pisani P, Lopez AD, Masuyer E. At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer 1994; 59: 494504.
  • 20
    Peto R, Lopez AD, Boreham J, et al. Mortality from smoking in developed countries, 1950–2000. Oxford, UK: Oxford University Press; 1994.
  • 21
    Jemal A, Chu KC, Tarone RE. Recent trends in lung cancer mortality in the United States. J Natl Cancer Inst 2001; 93: 277283.
  • 22
    Bray F, Tyczynski JE, Parkin DM. Going up or coming down? The changing phases of the lung cancer epidemic in the 15 European Union countries 1967–1999. Eur J Cancer 2004; 40: 96125.
  • 23
    Tyczynski JE, Bray F, Aareleid T, et al. Lung cancer mortality patterns in selected Central, Eastern and Southern European countires. Int J Cancer 2004; 109: 598610.
  • 24
    Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer 2004; 101: 327.
  • 25
    IARC Handbook on Cancer Prevention No. 7. Breast Cancer Screening. Lyon, France: International Agency for Research on Cancer; 2002.
  • 26
    Hewitt M, Breen N, Devesa S. Cancer prevalence and survivorship issues: analyses of the 1992 National Health Interview Survey. J Natl Cancer Inst 1999; 91: 14801486.
  • 27
    McPherson K, Steel CM, Dixon JM. Breast cancer—epidemiology, risk factors and genetics. Brit Med J 2000; 321: 624628.
  • 28
    Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries with special reference to dietary practices. Int J Cancer 1975; 15: 617631.
  • 29
    Prentice RL, Sheppard L. Dietary fat and cancer: consistency of the epidemiologic data, and disease prevention that may follow from a practical reduction in fat consumption. Cancer Causes Control 1990; 1: 8187.
  • 30
    McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 1994; 3: 687695.
  • 31
    Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 2002; 31: 925943.
  • 32
    McMichael AJ, McCall MG, Hartchorne JM, Woodings TL. Patterns of gastrointestinal cancer in European migrants to Australia: the role of dietary change. Int J Cancer 1980; 5: 431437.
  • 33
    Kolonel LN, Hinds MW, Hankin JH. Cancer Patterns among Migrant and Native-born Japanese in Hawaii in Relation to Smoking, Drinking and Dietary Habits. In: GelboinHV, MacMahonB, MatsushimaT, et al. (eds). Genetic and Environmental factors in Experimental and Human Cancer. Tokyo, Japan: Japan Scientific Societies Press; 1980: 327340.
  • 34
    ParkinDM, WhelanSL, FerlayJ, et al. (eds). Cancer Incidence in Five Continents. Vol. VIII, IARC Scientific Publications No. 155. Lyon, France: International Agency for Research on Cancer; 2002.
  • 35
    Holcombe C. Helicobacter pylori: the African enigma. Gut 1992; 33: 429431.
  • 36
    ParkinDM, FerlayJ, Hamdi-ChérifM, et al. (eds). Cancer in Africa: Epidemiology and Prevention. IARC Scientific Publications No. 153. Lyon, France: International Agency for Research on Cancer; 2003.
  • 37
    Coggon D, Osmond C, Barker DJ. Stomach cancer and migration with England and Wales. Br J Cancer 1990; 61: 573574.
  • 38
    IARC Monograph on the Evaluation of Carcinogenic Risks to Humans, Vol. 61. Schistosomes, Liver Flukes and helicobacter pylori. Lyon, France: International Agency for Research on Cancer; 1994.
  • 39
    Sitas F, Yarnell J, Forman D. Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut 1992; 33: 1582.
  • 40
    World Cancer Research Fund (WCRF) Panel. Diet, nutrition and the prevention of cancer: a global perspective. Washington, DC, USA: World Cancer Research Fund; 1997.
  • 41
    Palli D. Epidemiology of gastric cancer: an evaluation of available evidence. J Gastroenterol 2000; 35: S84S89.
  • 42
    IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Vol. 83: Tobacco Smoke and Involuntary Smoking. Lyon, France: International Agency for Research on Cancer; 2004.
  • 43
    Muñoz N, Franceschi S. Epidemiology of gastric cancer and perspectives for prevention. Salud Publica Mex 1997; 39: 318330.
  • 44
    Banatvala N, Mayo K, Megraud F, et al. The cohort effect and Helicobacter pylori. J Infect Dis 1993; 168: 219221.
  • 45
    Roosendaal R, Kulpers EJ, Buiterwerf J, et al. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol 1997; 92: 14801482.
  • 46
    MillerBA, KolonelLN, BernsteinL, et al., eds. Racial/Ethnic Patterns of Cancer in the United States 1988–1992. NIH Publication No. 96–4104. Bethesda, MD: National Cancer Institute; 1996.
  • 47
    Bouchardy C, Mirra AP, Khlat M, et al. Ethnicity and cancer risk in Sao Paulo, Brazil. Cancer Epidemiol Biomarkers Prev 1991; 1: 2127.
  • 48
    Shibata A, Whittemore A. Genetic predisposition to prostate cancer: possible explanations for ethnic differences in risk. Prostate 1997; 32: 6572.
  • 49
    Potosky AL, Kessler Gridley G, et al. Rise in prostatic cancer incidence associated with increased use of transurethral resection. J Natl Caner Inst 1990; 82: 16241628.
  • 50
    Brawley OW. Prostate carcinoma incidence and patient mortality. The effects of screening and early detection. Cancer 1997; 80: 18571863.
  • 51
    Chu KC, Tarone RE, Freeman HP. Trends in prostate cancer mortality among black men and white men in the United States. Cancer 2003; 97: 15071516.
  • 52
    Hsing AW, Tsao L, Devesa SS. International trends and patterns of cancer incidence and mortality. Int J Cancer 2000; 85: 6067.
  • 53
    Oliver SE, May MT, Gunnell D. International trends in prostate-cancer mortality in the ‘PSA era’. Int J Cancer 2001; 92: 893898.
  • 54
    Baade PD, Coory MD, Aitken JF. International trends in prostate-cancer mortality: the decrease is continuing and spreading. Cancer Causes Control 2004; 15: 237241.
  • 55
    Donato F, Boffetta P, Puoti MA. Meta-analysis of epidemiological studies on the combined effect of Hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998; 75: 347354.
  • 56
    Tanaka H, Hiyama T, Tsukuma H, et al. Prevalence of second generation antibody to hepatits C antibody among voluntary blood donors in Osaka, Japan. Cancer Causes Control 1994; 5: 409413.
  • 57
    Parkin DM, Pisani P, Muñoz N, Ferlay J. The Global Health Burden of Infection Associated Cancer, in Weiss RA, Beral V, Newton R (eds). Infections and Human Cancer. Cancer Surveys 1999; 33: 533.
  • 58
    Parkin DM, Ohshima H, Srivatanukul P, Vatanasapt V. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenese and prevention. Cancer Epidemiol Biomarkers Prev 1993; 2: 537544.
  • 59
    Chang MH, Chen CJ, Lai MS, et al. Universal Hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997; 336: 18551859.
  • 60
    Gustafsson L. Pontén J, Bergström R, Adami HO. International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer 1997; 71: 159165.
  • 61
    Dorn HF, Cutler SJ. Morbidity from cancer in the United States: Parts I and II. Public Health Monograph No. 56. Washington, DC: US Department of Health, Education, and Welfare; 1959.
  • 62
    Sadjadi A, Malekzadeh R, Derakhshan MH, et al. Cancer occurrence in Ardabil. Results of a population-based cancer registry from Iran. Int J Cancer 2003; 107: 113118.
  • 63
    Bosch FX, Lorincz A, Muñoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244265.
  • 64
    Muñoz N, Bosch FX, Shah KV, Meheus A. The epidemiology of cervical cancer and human papillomavirus. IARC Scientific Publication No. 119. Lyon, France: International Agency for Research on Cancer; 1992.
  • 65
    Pham THA, Nguyen NT, Herrero R, et al. Human papillomavirus infection among women in south and North Vietnam. Int J Cancer 2002; 104: 213230.
  • 66
    Muñoz N, Day N. Esophageal Cancer, in SchottenfeldD, FraumeniJF (eds). Cancer Epidemiology and Prevention. 2nd ed. New York: Oxford University Press; 1996.
  • 67
    Yokoyama A, Kato H, Yokoyama T, et al. Genetic polymorphisms of alcohol and aldehyde dehydrogenase and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men and esophageal squamous cell carcinoma. Carcinogenesis 2002; 23: 18511859.
  • 68
    Goedde HW, Agarwal DP, Fritze G, et al. Distribution of ADH2 and ALDH2 genotypes in different populations. Human Genet 1992; 88: 344346.
  • 69
    Vizcaino AP, Moreno V, Lambert R, et al. Time trends in incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1975. Int J Cancer 2002; 99: 860868.
  • 70
    Chow WH, Blot WJ, Vaughan TL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998; 90: 150155.
  • 71
    Lagergren J, Bergström R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardis. Ann Intern Med 1999; 130: 883890.
  • 72
    Yu MC, Skipper PL, Taghizadeh K, et al. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. J Natl Caner Inst 1994; 86: 712716.
  • 73
    Yu MC, Ross RK, Chan KK, et al. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black, and Asian smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 1995; 4: 861864.
  • 74
    JaffeES, HarrisNL, SteinH, VardimanJW, eds. WHO Classification of Tumors. Pathology and Genetics of Tumors of the Haematopoietic and Lymphoid Tissues. Lyon, France: International Agency for Research on Cancer; 2001.
  • 75
    Remick SC. Acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Cancer Control 1995; 2: 97103.
  • 76
    Melbye M, Trichopoulos D. Non-Hodgkin's lymphomas, in AdamiHO, HunterD, TrichopoulosD (eds). Textbook of Cancer Epidemiology. Oxford, UK: Oxford University Press; 2002.
  • 77
    Arisawa K, Soda M, Endo S, et al. Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer 2000; 85: 319324.
  • 78
    Harge P, Devesa SS. Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence. Cancer Res 1992; 52: 5566s5569s.
  • 79
    Eltorn MA, Jemal A, Mbulaiteye SM, et al. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1988. J Natl Cancer Inst 2002; 94: 12041210.
  • 80
    Bergström A, Pisani P, Wolk A, et al. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001; 91: 421430.
  • 81
    IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 72, Hormonal Contraception and Postmenopausal Hormonal Therapy. Lyon, France: International Agency for Research on Cancer, 1999.
  • 82
    IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 70, Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France: International Agency for Research on Cancer; 1997.
  • 83
    Cozen W, Katz J, Mack TM. Risk patterns of Hodgkin's disease in Los Angeles vary by cell type. Cancer Epidemiol Biomarker Prev 1992; 1: 261268.
  • 84
    Mueller NE. Hodgkin's Disease, in SchottenfeldD, FraumeniJF, Jr (eds). Cancer Epidemiology and Prevention. 2nd ed. New York: Oxford University Press; 1996: 893919.
  • 85
    Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997; 70: 375382.
  • 86
    Oettlé AG. Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes. Acta Unio Int Conra Cancrum 1962; 18: 330363.
  • 87
    Templeton AC. Kaposi's Sarcoma, in SommersSC, RosenPP (eds). Pathology Annual. New York: Century-Crofts; 1981: 315336.
  • 88
    Biggar RJ, Horn J, Fraumeni JF, et al. Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973–1981. J Natl Cancer Inst 1984; 73: 8994.
  • 89
    Rabkin CS, Biggar RJ, Horn JW. Increasing incidence of cancer associated with the human immunodeficiency virus epidemic. Int J Cancer 1991; 47: 692696.
  • 90
    Sriplung H, Parkin DM. Trends in the incidence of acquired immunodeficiency syndrome-related malignancies in Thailand. Cancer 2004; 101: 26602666.
  • 91
    Newton R, Sitas F, Dedicoat M, Ziegler JL. HIV infection and Cancer, in EssexM, MboupS, KankiPJ, et al. (eds). AIDS in Africa. 2nd ed. New York: Kluwer Academic; 2002.
  • 92
    Sitas F, Pacella-Norman R, Carrara H, et al. The spectrum of HIV-1 related cancers in South Africa. Int J Cancer 2000; 88: 489492.
  • 93
    International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000; 92: 18231830.